Access

News

Nature 406, 5 (6 July 2000) | doi:10.1038/35017714

Open Innovation Challenges

naturejobs

NIH urged to cap profits made on publicly funded research

Colin Macilwain

The US National Institutes of Health (NIH) is caught in the crossfire over one of the most contentious issues in the US presidential campaign: the high cost of therapeutic drugs.In particular, the medical agency is under political pressure to cap or recover profits on drugs whose development was based on publicly funded research.